Giuseppe Giaccone, MD, PhD, highlights the difficulties with funding for research focused on rare cancers.
Giuseppe Giaccone, MD, PhD
Advertisement
Articles by Giuseppe Giaccone, MD, PhD
Giuseppe Giaccone, MD, PhD, discusses recent data with investigational therapies for patients with thymic cancer.
Giuseppe Giaconne, MD, PhD, discusses why thymic cancers can be difficult to classify histologically, so the actual incidence is unclear.
Giuseppe Giaconne, MD, PhD, and Yongfeng He, PhD, discuss how cancers of the thymus, a small organ located in the mediastinum above the heart, are uncommon and understudied.

Giuseppe Giaccone, MD, PhD, discusses current treatment options in non–small cell lung cancer.
Advertisement
Latest Updated Articles
Dr. Giaccone on Treatment Options in NSCLCPublished: October 1st 2020 | Updated:
- Dr. Giaccone on Investigational Agents in Thymic Cancers
Published: October 21st 2022 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Ultra-Sensitive ctDNA and CSF Liquid Biopsy May Refine Monitoring and Adaptive Trial Designs in Metastatic Breast Cancer
4
Lurbinectedin-Based Triplet Shows Clinical Benefit in Advanced Soft Tissue Sarcoma
5

